1. Home
  2. LCUT vs XFOR Comparison

LCUT vs XFOR Comparison

Compare LCUT & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCUT
  • XFOR
  • Stock Information
  • Founded
  • LCUT 1945
  • XFOR 2014
  • Country
  • LCUT United States
  • XFOR United States
  • Employees
  • LCUT N/A
  • XFOR N/A
  • Industry
  • LCUT Industrial Machinery/Components
  • XFOR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LCUT Consumer Discretionary
  • XFOR Health Care
  • Exchange
  • LCUT Nasdaq
  • XFOR Nasdaq
  • Market Cap
  • LCUT 123.6M
  • XFOR 118.4M
  • IPO Year
  • LCUT 1991
  • XFOR N/A
  • Fundamental
  • Price
  • LCUT $6.12
  • XFOR $0.51
  • Analyst Decision
  • LCUT Strong Buy
  • XFOR Strong Buy
  • Analyst Count
  • LCUT 2
  • XFOR 3
  • Target Price
  • LCUT $10.25
  • XFOR $3.50
  • AVG Volume (30 Days)
  • LCUT 42.9K
  • XFOR 2.9M
  • Earning Date
  • LCUT 03-11-2025
  • XFOR 11-13-2024
  • Dividend Yield
  • LCUT 2.78%
  • XFOR N/A
  • EPS Growth
  • LCUT N/A
  • XFOR N/A
  • EPS
  • LCUT N/A
  • XFOR N/A
  • Revenue
  • LCUT $670,888,000.00
  • XFOR $1,123,000.00
  • Revenue This Year
  • LCUT $0.98
  • XFOR N/A
  • Revenue Next Year
  • LCUT $2.58
  • XFOR $652.72
  • P/E Ratio
  • LCUT N/A
  • XFOR N/A
  • Revenue Growth
  • LCUT N/A
  • XFOR N/A
  • 52 Week Low
  • LCUT $5.25
  • XFOR $0.26
  • 52 Week High
  • LCUT $11.68
  • XFOR $1.60
  • Technical
  • Relative Strength Index (RSI)
  • LCUT 56.34
  • XFOR 42.67
  • Support Level
  • LCUT $5.33
  • XFOR $0.43
  • Resistance Level
  • LCUT $5.75
  • XFOR $0.89
  • Average True Range (ATR)
  • LCUT 0.30
  • XFOR 0.09
  • MACD
  • LCUT 0.03
  • XFOR -0.04
  • Stochastic Oscillator
  • LCUT 88.76
  • XFOR 17.61

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.

About XFOR X4 Pharmaceuticals Inc.

X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

Share on Social Networks: